pubrio
Alkem Laboratories Ltd. logo

Alkem Laboratories Ltd.

Privately Held
alkemlabs.com
제약18,000+ employeesFounded 1973🇮🇳 인도

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India's largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries'.

설립
1973
직원
18,000+
산업
제약
회사 유형
Privately Held
주식
nse: ALKEM.NS
본사
🇮🇳Alkem House, Senapati Bapat Marg, Mumbai, Maharashtra, In, 400 013 (+2)
전문 분야
연구제약의료
0 / 1
활성 시장
인도네시아
0
신규 시장
낮음
신뢰도
대부분 초기 시그널
0%
모멘텀
이전 기간 대비
32 / 100
확장 점수
성장 중
단계1투자 중
시그널 없음 · 최근 90일

글로벌 확장

실시간
인도네시아
단계
탐색 중투자 중진입 중운영 중

시장 진입 타임라인

이 회사가 각 시장에 진입한 순서 — 오래된 순부터 최신 순까지

1
🇮🇩인도네시아1st 진입 시장 · 2025진전 중
투자 중
시그널 1건투자 중 단계
현재 단계투자 중자원 투입 중
신뢰도28%낮음
추적 시작2025첫 시그널

최근 시그널

가입하고 전체 시그널 피드를 확인하세요

알아두면 좋은 정보

Alkem Laboratories Ltd. 관련 자주 묻는 질문

Alkem Laboratories Ltd.의 사업, 시장, 성장 시그널에 대한 빠른 답변입니다.

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India's largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries'.

오늘 바로 여정을 시작하세요

플랫폼부터 시작해도, 대화부터 시작해도 좋습니다

직접 Pubrio 를 사용하거나, 연구·리드 생성·데이터 통합을 저희 팀에 맡겨 보세요.

팀과 상담하기
Start Journey Image
pubrio

Pubrio는 50개 이상의 로컬 소스에서 비즈니스·인물·의도 데이터를 통합해 하나의 글로벌 그래프로 제공, 시장 전체 가시성을 확보하게 합니다.

© 2026 Pubrio. 모든 권리 보유.